Subject(s)

Bone Neoplasms , Hemangioendothelioma, Epithelioid , Liver Neoplasms , Lung Neoplasms , Neoplasms, Multiple Primary , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/therapeutic use , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/drug therapy , Cyclophosphamide/administration & dosage , Cyclophosphamide/therapeutic use , Fatal Outcome , Female , Hemangioendothelioma, Epithelioid/diagnosis , Hemangioendothelioma, Epithelioid/diagnostic imaging , Hemangioendothelioma, Epithelioid/drug therapy , Hemangioendothelioma, Epithelioid/pathology , Humans , Liver/pathology , Liver Neoplasms/diagnosis , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Lung/pathology , Lung Neoplasms/diagnosis , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Middle Aged , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/drug therapy , Neoplasms, Multiple Primary/pathology , Radiography, Abdominal , Radiography, Thoracic , Radionuclide Imaging , Time Factors , Tomography, X-Ray Computed